Published February, 2022
By Richard Russell and Richard EK Russell
Publisher: Adis
Rating:
in-stock

The fourth edition of this popular book captures the latest updates in within the management and treatment of patients with COPD.

---

Published January, 2022
By Sebastian L. Johnston and David J. Jackson
Publisher: Adis
Rating:
in-stock

This concise pocketbook provides readers with a complete overview of the background of asthma and discusses treatment options, emerging therapies, alternative therapies, and the most up-to-date guidelines.

---

Published January, 2022
By Jean-Michel Gracies
Publisher: Adis
Rating:
in-stock

This book is an informative guide for both the patient and therapist, and provides a series of exercises that target the most important muscles for those with spastic paresis.

---

Published March, 2019
By Edoardo Spina and Gianluca Trifiro
Publisher: Adis
Rating:
in-stock

---

Published March, 2019
By Carl Asche
Publisher: Adis
Rating:
in-stock

---

Published July, 2018
By Zaheer-Ud-Din Babar
Publisher: Adis
Rating:
in-stock

A comprehensive and granular insight into the challenges of promoting rational medicine, this book serves as an essential resource for health policy makers and researchers interested in national medicines policies.

---

Published July, 2018
By Anne A. Gershon, C. Peter N. Watson and Michael N. Oxman
Publisher: Adis
Rating:
in-stock

A section on postherpetic neuralgia includes important information on the effect of herpes zoster and postherpetic neuralgia on quality of life, the neuropathology and pathophysiological mechanisms in postherpetic neuralgia, and the new concept of persistent ganglionitis as the cause of postherpetic neuralgia.

---

Published July, 2018
By Janet Martin and Laura Sampietro-Colom
Publisher: Adis
Rating:
in-stock

---

Published July, 2018
By Carlos A. Zarate Jr. and Sanjay J. Mathew
Publisher: Adis
Rating:
in-stock

---

Published June, 2018
By Iftekhar Mahmood and Gilbert Burckart
Publisher: Adis
Rating:
in-stock

With the advent of pediatric exclusivity, and requirements to conduct clinical studies in children, an emphasis has been placed on finding a safe and efficacious dose of a drug in children.

---